Matthias Huber Selected Research

Matthias Huber Research Topics

Disease

5	Drug-Related Side Effects and Adverse Reactions 01/2018 - 07/2007
3	Hypertension (High Blood Pressure) 01/2013 - 01/2006
2	Thrombocytopenia (Thrombopenia) 01/2018 - 10/2017
2	Agranulocytosis (Granulocytopenia) 02/2015 - 03/2014
2	Type 2 Diabetes Mellitus (MODY) 10/2013 - 01/2011
2	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2007 - 11/2006
1	Neoplasms (Cancer) 01/2022
1	Thrombosis (Thrombus) 10/2017
1	Postoperative Pain 02/2015
1	Headache (Headaches) 02/2015
1	Alzheimer Disease (Alzheimer's Disease) 01/2015
1	Glaucoma 01/2013
1	Dementia (Dementias) 01/2013
1	Infections 12/2012
1	Inflammation (Inflammations) 12/2012
1	Liver Diseases (Liver Disease) 12/2012
1	Retinal Detachment (Retinal Detachments) 12/2012
1	Cardiovascular Diseases (Cardiovascular Disease) 09/2012
1	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2012
1	Choroidal Neovascularization 01/2012
1	Macular Degeneration (Age-Related Maculopathy) 01/2012
1	Obesity 01/2011
1	Body Weight (Weight, Body) 01/2011
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2011
1	Albuminuria 06/2010
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 06/2010
1	Stroke (Strokes) 02/2008
1	Diabetes Mellitus 10/2006
1	Uveitis 07/2006
1	Meningeal Carcinomatosis 09/2005
1	Hyperglycemia 02/2003

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 03/2014 - 12/2012
2	Heparin (Liquaemin)FDA LinkGeneric 01/2018 - 10/2017
2	Antihypertensive Agents (Antihypertensives)IBA 01/2013 - 01/2006
2	Retinaldehyde (Retinal)IBA 01/2012 - 01/2011
1	Dipyrone (Metamizole)IBA 02/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Amyloid (Amyloid Fibrils)IBA 01/2015
1	Melatonin Receptors (Melatonin Receptor)IBA 10/2013
1	Carbonic Anhydrase InhibitorsIBA 01/2013
1	Synthetic Prostaglandins (Prostaglandin Analogues)IBA 01/2013
1	Telmisartan (Micardis)FDA Link 01/2013
1	Linezolid (Zyvox)FDA Link 12/2012
1	Cidofovir (Vistide)FDA Link 12/2012
1	Anti-Infective Agents (Microbicides)IBA 12/2012
1	Antiviral Agents (Antivirals)IBA 12/2012
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2012
1	Rifabutin (Ansamycin)FDA Link 12/2012
1	Oxazolidinones (2 Oxazolidone)IBA 12/2012
1	FluoroquinolonesIBA 12/2012
1	Biological ProductsIBA 09/2012
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2012
1	pigment epithelium-derived factorIBA 01/2012
1	Angiopoietin-2IBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 01/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012
1	Triglycerides (Triacylglycerol)IBA 01/2011
1	CholesterolIBA 01/2011
1	Glucose (Dextrose)FDA LinkGeneric 01/2011
1	Type 2 Angiotensin ReceptorIBA 06/2010
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 06/2010
1	Messenger RNA (mRNA)IBA 06/2010
1	salicylhydroxamic acid (SHAM)IBA 06/2010
1	Lipocalin-2IBA 06/2010
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2008
1	SteroidsIBA 07/2006
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2006
1	Immunosuppressive Agents (Immunosuppressants)IBA 07/2006
1	DiureticsIBA 01/2006
1	Angiotensin IIIBA 01/2006
1	Methotrexate (Mexate)FDA LinkGeneric 09/2005
1	Fibronectins (Fibronectin)IBA 02/2003
1	Extracellular Matrix ProteinsIBA 02/2003

Therapy/Procedure

6	Therapeutics 01/2018 - 01/2006
2	Drug Therapy (Chemotherapy) 03/2014 - 01/2013
1	Smart Glasses 01/2022
1	Polypharmacy 01/2013
1	Home Nursing (Nursing, Home) 01/2013
1	Renal Dialysis (Hemodialysis) 01/2013
1	Contraindications 07/2007